The increased cell size and granularity, along with elevated expression of activation and checkpoint molecules HLA-DR, TIM-3, and CD163 in human CD14+ monocytes, indicate a monocyte hyperactivation syndrome in a subset of CD34+-cell-engrafted NSG-Quad mice. This evidence concerns the gene HAVCR2 and Down syndrome.